Foley is a sponsor at the 2nd annual conference on Corporate Intellectual Property in China on April 26-27, 2007.
Foley attorney TJ Hou from our Silicon Valley office will be speaking on “Assessing and Valuing Your Internal IP Portfolio” on April 27.
As your intellectual property is valuable to create market monopolies, it needs to be commercialized, licensed or enforced. This conference focuses on sharpening your licensing strategies and skills as well as gives a unique opportunity to meet fellow peers and learn best practices for how to successfully manage IP resources to maximize the value for both your and your licensee’s business.
Key sessions include:
- Panel discussions on:
- Implication of the new IP regulations
- Commercialize VS Assert
- Implication of the new IP regulations
- Mock Patent Deposition and Hearing
- Case Study & Best Practices focusing on:
- Globalization and international licensing
- Due diligence for executing licensing strategy
- Patent commercialized and innovative measures to maximize the value
- Align product lifecycles to develop licensing calendar
- Assess and value IP portfolio
- IP Asset Management
- Globalization and international licensing
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.